• Intervention RX
  • Enoxaparin in Primary PCI: Insights from the ATOLL Trial

  • Cardiology Today's Intervention, July/August
    Johanne Silvain, MD PhD; Gilles Montalescot, MD, PhD
  • The randomized ATOLL trial is an academic trial led by the ACTION Research group that aimed to show the superiority of enoxaparin used as an IV drug when...More »